Weiss Ratings Daily

Donald Trump is pursuing an “America First” agenda, and that’s been great for stocks and sectors in the industries his policies should benefit the most. That includes defense, financials , and...

Everyone has an opinion on health insurance costs -- and debate over the future of the health insurance industry continues to rage in Washington. But what does the actual data show? Who pays the...

We finally got one this week – a 1% decline in the Standard & Poor’s 500 Index. Tuesday’s drop was the first one of that magnitude since October. Some 87% of the index’s components fell on the...

We’ve long known that the Weiss Ratings Model gives us insights to a company’s future prospects, but I’m also finding we can use it to gauge the health of the general market. Let me explain… ...

Donald Trump made no secret on the campaign trail about his desire to shell out billions to make America’s military great again. Now that he’s president, he’s following through on his pledge....

The Federal Reserve did exactly what I predicted it would: Raise interest rates for the third time in this rate-hiking cycle. Wednesday’s move boosted the benchmark federal funds rate to a range...

Every few years, a new trend emerges, it gets hyped up, and everyone wants to invest in it. All too often, though, the sector doesn’t live up to the hype for one reason or another, and it tanks....

The countdown to Wednesday’s Federal Reserve interest rate hike is on! I trust you’ll be as well-prepared as anyone for it, given the advanced warning we’ve given you at Weiss Ratings. But here is...

Janet Yellen and her Federal Reserve colleagues will meet to discuss interest rates next week. My take: Another rate hike is locked in! It would raise the federal funds rate from its current...

Small cap biotechnology stocks are some of my favorite investments. The innovations and cures you can find companies working on, and the rocketing of their stock prices once approvals are...